Greenwood BM, Fidock DA, Kyle DE, Kappe SHI, Alonso PL, Collins FH, et al. Malaria: progress, perils, and prospects for eradication. J Clin Invest. 2008;118:1266–76.
WHO. World malaria report 2022. Geneva: World Health Organization; 2022.
Oliveira-Ferreira J, Lacerda MV, Brasil P, Ladislau JL, Tauil PL, Daniel-Ribeiro CT. Malaria in Brazil: an overview. Malar J. 2010;9:115.
Battle KE, Lucas TCD, Nguyen M, Howes RE, Nandi AK, Twohig KA, et al. Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000–17: a spatial and temporal modelling study. Lancet. 2019;394:332–43.
Cunha MG, Santos CS, Raiol M, Costa SPT, Ventura AMR, Póvoa MM, et al. Mixed Plasmodium malariae infections were underdetected in a malaria endemic area in the Amazon Region, Brazil. Am J Trop Med Hyg. 2021;105:1184–6.
Day NPJ, Hien TT, Schollaardt T, Loc PP, Chuong LV, Chau TTH, et al. The Prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. J Infect Dis. 1999;180:1288–97.
Doolan DL, Sedegah M, Hedstrom RC, Hobart P, Charoenvit Y, Hoffman SL. Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity. J Exp Med. 1996;183:1739–46.
Medina TS, Costa SP, Oliveira MD, Ventura AM, Souza JM, Gomes TF, et al. Increased interleukin-10 and interferon-γ levels in Plasmodium vivax malaria suggest a reciprocal regulation which is not altered by IL-10 gene promoter polymorphism. Malar J. 2011;10:264.
Kumar A, Singh KP, Bali P, Anwar S, Kaul A, Singh OP, et al. iNOS polymorphism modulates iNOS/NO expression via impaired antioxidant and ROS content in P. vivax and P. falciparum infection. Redox Biol. 2018;15:192–206.
Levesque MC, Hobbs MR, O’Loughlin CW, Chancellor JA, Chen Y, Tkachuk AN, et al. Malaria severity and human nitric oxide synthase type 2 (NOS2) promoter haplotypes. Hum Genet. 2010;127:163–82.
Kern P, Dietrich M, Hemmer C, Wellinghausen N. Increased levels of soluble Fas ligand in serum in Plasmodium falciparum malaria. Infect Immun. 2000;68:3061–3.
Leiriao P, Mota MM, Rodriguez A. Apoptotic Plasmodium- infected hepatocytes provide antigens to liver dendritic cells. J Infect Dis. 2005;191:1576–81.
Kaushansky A, Metzger PG, Douglass AN, Mikolajczak SA, Lakshmanan V, Kain HS, et al. Malaria parasite liver stages render host hepatocytes susceptible to mitochondria-initiated apoptosis. Cell Death Dis. 2013;4:e762.
Kaushansky A, Ye AS, Austin LS, Mikolajczak SA, Vaughan AM, Camargo N, et al. Suppression of host p53 is critical for Plasmodium liver-stage infection. Cell Rep. 2013;3:630–7.
Pinzon-Charry A, Woodberry T, Kienzle V, McPhun V, Minigo G, Lampah DA, et al. Apoptosis and dysfunction of blood dendritic cells in patients with falciparum and vivax malaria. J Exp Med. 2013;210:1635–46.
Hojo-Souza NS, Pereira DB, Mendes TA, Passos LS, Gazzinelli-Guimarães AC, Gazzinelli-Guimarães PH, et al. CD4+ T cells apoptosis in Plasmodium vivax infection is mediated by activation of both intrinsic and extrinsic pathways. Malar J. 2015;14:5.
Lacerda-Queiroz N, Riteau N, Eastman RT, Bock KW, Orandle MS, Moore IN, et al. Mechanism of splenic cell death and host mortality in a Plasmodium yoelii malaria model. Sci Rep. 2017;7:10438.
Totino PRR, Daniel-Ribeiro CT, de Ferreira-da-Cruz MF. Evidencing the role of erythrocytic apoptosis in malarial anemia. Front Cell Infect Microbiol. 2016;6:176.
Sena-dos-Santos C, Braga-da-Silva C, Marques D, dos Santos Azevedo, Pinheiro J, Ribeiro-dos-Santos Â, Cavalcante GC. Unraveling cell death pathways during malaria infection: what do we know so far? Cells. 2021;10:479.
Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35:495–516.
Cavalcante GC, Schaan AP, Cabral GF, Santana-da-Silva MN, Pinto P, Vidal AF, et al. A Cell’s fate: an overview of the molecular biology and genetics of apoptosis. IJMS. 2019;20:4133.
Cavalcante GC, de Moraes MR, Valente CMD, Silva CS, Modesto AAC, de Assumpção PB, et al. Investigation of INDEL variants in apoptosis: the relevance to gastric cancer. BMC Med Genet. 2020;21:207.
Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. In: Barry R, editor. A laboratory manual. 2nd ed. New York: Cold Spring Harbor Laboratory Press; 1989.
Batista-dos-Santos SA, Freitas DRC, Raiol M, Cabral GF, Feio AC, Póvoa MM, et al. Strategy to improve malaria surveillance system preventing transfusion-transmitted malaria in blood banks using molecular diagnostic. Malar J. 2018;17:344.
Palha T, Gusmão L, Ribeiro-Rodrigues E, Guerreiro JF, Ribeiro-dos-Santos Â, Santos S. Disclosing the genetic structure of Brazil through analysis of male lineages with highly discriminating haplotypes. PLoS ONE. 2012;7:e40007.
Schaan AP, Costa L, Santos D, Modesto A, Amador M, Lopes C, et al. mtDNA structure: the women who formed the Brazilian Northeast. BMC Evol Biol. 2017;17:185.
Greenberg JH, Turner CG, Zegura SL, Campbell L, Fox JA, Laughlin WS, et al. The settlement of the Americas: a comparison of the linguistic, dental, and genetic evidence [and Comments and Reply]. Curr Anthropol. 1986;27:477–97.
Fagundes NJR, Kanitz R, Eckert R, Valls ACS, Bogo MR, Salzano FM, et al. Mitochondrial population genomics supports a single pre-clovis origin with a coastal route for the peopling of the Americas. Am J Hum Genet. 2008;82:583–92.
Introdução a uma história indígena (Cunha 1992)—Biblioteca Digital Curt Nimuendajú. http://www.etnolinguistica.org/hist:p9-24
Santos NPC, Ribeiro-Rodrigues EM, Ribeiro-dos-Santos ÂKC, Pereira R, Gusmão L, Amorim A, et al. Assessing individual interethnic admixture and population substructure using a 48-insertion-deletion (INSEL) ancestry-informative marker (AIM) panel. Hum Mutat. 2010;31:184–90.
de Ramos BRA, Mendes ND, Tanikawa AA, Amador MAT, dos Santos NPC, dos Santos SEB, et al. Ancestry informative markers and selected single nucleotide polymorphisms in immunoregulatory genes on preterm labor and preterm premature rupture of membranes: a case control study. BMC Pregnancy Childbirth. 2016;16:30.
Andrade RB, Amador MAT, Cavalcante GC, Leitão LPC, Fernandes MR, Modesto AAC, et al. Estimating Asian contribution to the Brazilian population: a new application of a validated set of 61 ancestry informative markers. G3 Genes. 2018;8:3577–82.
Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. Genetics. 2000;155:945–59.
Barbier M, Atkinson A, Fumoux F, Rihet P. IL12B polymorphisms are linked but not associated with Plasmodium falciparum parasitemia: a familial study in Burkina Faso. Genes Immun. 2008;9:405–11.
Sortica VA, Cunha MG, Ohnishi MDO, Souza JM, Ribeiro-dos-Santos ÂKC, Santos SEB, et al. Role of IL6, IL12B and VDR gene polymorphisms in Plasmodium vivax malaria severity, parasitemia and gametocytemia levels in an Amazonian Brazilian population. Cytokine. 2014;65:42–7.
Padilla-Rodríguez JC, Olivera MJ, Guevara-García BD. Parasite density in severe malaria in Colombia. PLoS ONE. 2020;15:e0235119.
Anstey NM, Russell B, Yeo TW, Price RN. The pathophysiology of vivax malaria. Trends Parasitol. 2009;25:220–7.
Driss A, Hibbert JM, Wilson NO, Iqbal SA, Adamkiewicz TV, Stiles JK. Genetic polymorphisms linked to susceptibility to malaria. Malar J. 2011;10:271.
de Mendonça VRR, Goncalves MS, Barral-Netto M. The host genetic diversity in malaria infection. J Trop Med. 2012;2012:940616.
Riley EM, Stewart VA. Immune mechanisms in malaria: new insights in vaccine development. Nat Med. 2013;19:168–78.
da Furini AAC, Cassiano GC, Petrolini Capobianco M, dos Santos SEB, Dantas Machado RL. Frequency of TNFA, INFG, and IL10 gene polymorphisms and their association with malaria vivax and genomic ancestry. Mediators Inflamm. 2016;2016:5168363.
Pinto P, Salgado C, Santos NPC, Santos S, Ribeiro-dos-Santos Â. Influence of genetic ancestry on INDEL markers of NFKβ1, CASP8, PAR1, IL4 and CYP19A1 genes in leprosy patients. PLoS Negl Trop Dis. 2015;9:e0004050.
da Leal DFVB, da Santana Silva MN, de Fernandes DCO, Rodrigues JCG, da Barros MCC, Pinto PDC, et al. Amerindian genetic ancestry as a risk factor for tuberculosis in an Amazonian population. PLoS ONE. 2020;15:e0236033.
Mario-Vásquez JE, Naranjo-González CA, Montiel J, Zuluaga LM, Vásquez AM, Tobón-Castaño A, et al. Association of variants in IL1B, TLR9, TREM1, IL10RA, and CD3G and native American ancestry on malaria susceptibility in Colombian populations. Infect Genet Evol. 2021;87:104675.
Chatterjee K, Williamson A-L, Hoffman M, Dandara C. CASP8 promoter polymorphism is associated with high-risk HPV types and abnormal cytology but not with cervical cancer. J Med Virol. 2011;83:630–6.
Stumbrytė-Kaminskienė A, Gudlevičienė Ž, Dabkevičienė D, Mackevičienė I. Combined effect of HPV and several gene SNPs in laryngeal cancer. Medicina. 2020;56:81.
Sun T, Gao Y, Tan W, Ma S, Shi Y, Yao J, et al. A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nat Genet. 2007;39:605–13.
Kurup SP, Anthony SM, Hancox LS, Vijay R, Pewe LL, Moioffer SJ, et al. Monocyte-derived CD11c+ cells acquire Plasmodium from hepatocytes to prime CD8 T cell immunity to liver-stage malaria. Cell Host Microb. 2019;25:565-577.e6.
Kurup SP, Butler NS, Harty JT. T cell-mediated immunity to malaria. Nat Rev Immunol. 2019;19:457–71.
Xu H, Wipasa J, Yan H, Zeng M, Makobongo MO, Finkelman FD, et al. The mechanism and significance of deletion of parasite-specific CD4 + T cells in malaria infection. J Exp Med. 2002;195:881–92.
Strasser A, Jost PJ, Nagata S. The many roles of FAS receptor signaling in the immune system. Immunity. 2009;30:180–92.
Arruda JEG, Freitas FB, Cassiano GC, Ishak R, Machado RLD, Póvoa MM, et al. The polymorphism rs2234767 (-1377 G>A) in the FAS gene may be associated with Plasmodium vivax in the Brazilian Amazon. BJD. 2021;7:7605–13.
Schuldt K, Kretz CC, Timmann C, Sievertsen J, Ehmen C, Esser C, et al. A −436C>A polymorphism in the human FAS gene promoter associated with severe childhood malaria. PLoS Genet. 2011;7:e1002066.
Auton A, Abecasis GR, Altshuler DM, et al. A global reference for human genetic variation. Nature. 2015;526:68–74.
